Contributions de l’utilisateur
- 30 mars 2018 à 23:04 (diff | hist) . . (+3 817) . . N F1 with non-targets24. Intriguingly, an evolutionary conserved house of UPF1 is (Page créée avec « Here provided the additional lately demonstrated function of SMG5-7 in linking UPF1 to mRNA decay14,16?9,21,23, we considered the alternative but not necessarily mutually... ») (actuel)
- 30 mars 2018 à 12:05 (diff | hist) . . (+3 924) . . N Ent evidence for hyperphosphorylation as a mechanism permitting UPF1, the central (Page créée avec « Certainly, slowing NMD by inhibiting late-acting components [http://www.medchemexpress.com/AZD-8055.html AZD-8055 web] triggers UPF1 hyperphosphorylation, which in turn en... ») (actuel)
- 30 mars 2018 à 02:59 (diff | hist) . . (+3 352) . . N Evalence and frequency of TCM use was drawn from the 2001 NHI (Page créée avec « [https://dx.doi.org/10.2196/jmir.6472 jmir.6472] The FT utilization query in the questionnaire is as follows: In the past one particular month, have you undergone any ther... ») (actuel)
- 27 mars 2018 à 14:04 (diff | hist) . . (+4 591) . . N Evalence and frequency of TCM use was drawn in the 2001 NHI (Page créée avec « The difference involving TCM and FT lies in their legality.Evalence and frequency of TCM use was drawn in the 2001 NHI claims data. The [http://www.medchemexpress.com/GDC-... »)
- 24 mars 2018 à 10:38 (diff | hist) . . (-112) . . m S in ATP hydrolysis (DE636/637AA) or ATP binding (K498A (actuel)